Perspectives on microscopic imaging, evidence and responsible AI.

Designing traceable AI image workflows

How identifiers, metadata and timestamps turn a microscopic image workflow into something that can be reviewed later.

Why evidence-linked AI matters in research platforms

An assistant is only as useful as the sources behind it. Linking answers to records changes how they can be used.

From individual images to structured batch analysis

What changes when a workflow moves from one image at a time to structured records, distributions and exports.

AI and the Future of Leukemia Research

Explore how blood-cell imaging, AI and connected evidence can support leukemia research, and why meaningful evaluation extends beyond model accuracy.

By CellSight Editorial Team · September 13, 2026 · 2 min read

Advances in Leukemia Detection and Monitoring

Understand how molecular testing, flow cytometry, liquid-biopsy research and digital imaging contribute different evidence to leukemia investigations.

By CellSight Editorial Team · September 13, 2026 · 2 min read

Leukemia in Canada: Understanding the Numbers

Read Canadian leukemia statistics with context: distinguish new cases, deaths and prevalence, and understand the limits of annual projected estimates.

By CellSight Editorial Team · September 13, 2026 · 2 min read

Can AI Replace a Physician?

Explore the difference between automating a healthcare task and taking responsibility for care, with a practical perspective on human oversight of AI.

By CellSight Editorial Team · September 13, 2026 · 2 min read

AI, Human Error and Consistency in Leukemia Research

Explore how to evaluate AI and reader consistency in leukemia research, including why repeatable output alone does not establish clinical correctness.

By CellSight Editorial Team · September 13, 2026 · 2 min read

Oral Signs of Leukemia: Awareness and Assessment

Learn why unexplained oral changes deserve professional assessment, how symptoms can overlap, and why dental and oncology care should be coordinated.

By CellSight Editorial Team · September 13, 2026 · 2 min read

Liquid Biopsy in Leukemia: Promise and Limits

Explore liquid-biopsy research in leukemia, what plasma cell-free DNA may reveal, and why evidence from a defined setting cannot replace every marrow test.

By CellSight Editorial Team · September 13, 2026 · 2 min read

How AI May Support Faster Leukemia Investigations

Consider where AI may assist leukemia investigations and why processing speed, review time and the time to a clinical diagnosis must be measured separately.

By Dr. Nafiseh Memar Kermani · September 13, 2026 · 2 min read

Understanding Leukemia: A Clear Overview

A clear introduction to leukemia types, possible symptoms and the role of complementary tests, with links to reliable patient-information resources.

By CellSight Editorial Team · September 13, 2026 · 2 min read

How Is AI Used in Healthcare?

Explore healthcare AI through clearly defined tasks, from image analysis to information retrieval, and learn why useful output still needs evidence and review.

By CellSight Editorial Team · September 13, 2026 · 2 min read

AI in Leukemia Microscopy: A Research Review

Review selected AI studies in leukemia microscopy, covering hybrid models, cell detection and case-level learning, with practical limits on comparing results.

By CellSight Editorial Team · September 13, 2026 · 3 min read